Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Financial Flexibility Index
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥12.37 Million (operating CF CN¥8.20 Million minus capex CN¥4.18 Million) represents 0% of total liabilities (CN¥658.86 Million). Check 002566 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jilin Jian Yisheng Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Jilin Jian Yisheng Pharmaceutical Co Ltd across 20 annual periods. See Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Jilin Jian Yisheng Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jilin Jian Yisheng Pharmaceutical Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥112.38 Million | CN¥98.74 Million | CN¥630.35 Million | ▲ +51.7% |
| 2024 | 0.12x | CN¥74.89 Million | CN¥58.94 Million | CN¥637.22 Million | ▼ -65.7% |
| 2023 | 0.34x | CN¥244.90 Million | CN¥209.13 Million | CN¥714.30 Million | ▲ +31.3% |
| 2022 | 0.26x | CN¥187.22 Million | CN¥145.86 Million | CN¥717.18 Million | ▼ -46.0% |
| 2021 | 0.48x | CN¥322.17 Million | CN¥215.10 Million | CN¥666.08 Million | ▲ +14.9% |
| 2020 | 0.42x | CN¥279.45 Million | CN¥203.51 Million | CN¥663.86 Million | ▼ -20.6% |
| 2019 | 0.53x | CN¥232.57 Million | CN¥210.87 Million | CN¥438.66 Million | ▲ +29.2% |
| 2018 | 0.41x | CN¥241.04 Million | CN¥167.32 Million | CN¥587.49 Million | ▼ -12.4% |
| 2017 | 0.47x | CN¥354.15 Million | CN¥270.65 Million | CN¥756.40 Million | ▲ +1004.0% |
| 2016 | 0.04x | CN¥36.88 Million | CN¥-17.52 Million | CN¥869.67 Million | ▲ +117.0% |
| 2015 | -0.25x | CN¥-222.04 Million | CN¥-324.29 Million | CN¥888.65 Million | ▲ +64.7% |
| 2014 | -0.71x | CN¥-523.57 Million | CN¥-592.06 Million | CN¥739.24 Million | ▼ -30.4% |
| 2013 | -0.54x | CN¥-116.10 Million | CN¥-188.45 Million | CN¥213.79 Million | ▼ -123.7% |
| 2012 | 2.29x | CN¥166.62 Million | CN¥79.08 Million | CN¥72.81 Million | ▲ +318.1% |
| 2011 | -1.05x | CN¥-67.69 Million | CN¥-112.12 Million | CN¥64.52 Million | ▼ -263.9% |
| 2010 | 0.64x | CN¥99.62 Million | CN¥50.73 Million | CN¥155.66 Million | ▼ -44.0% |
| 2009 | 1.14x | CN¥167.66 Million | CN¥125.25 Million | CN¥146.67 Million | ▲ +348.5% |
| 2008 | 0.25x | CN¥32.48 Million | CN¥20.50 Million | CN¥127.43 Million | ▼ -63.1% |
| 2007 | 0.69x | CN¥94.08 Million | CN¥82.66 Million | CN¥136.08 Million | ▲ +58.5% |
| 2006 | 0.44x | CN¥43.33 Million | CN¥25.58 Million | CN¥99.35 Million | — |